Estimated Revenue: $1M to $10M
Funding Status: M&A
Headquarters: Cambridge, Massachusetts, United States
Total Funding: 427000000.0
Last Funding Date: 2022-09-12
Investors Number: 17.0
Founded Date: 2009-01-01
Technology: Alternative Medicine, Biotechnology, Health Care, Therapeutics
Industry: End-to-End Drug Development
Last Funding Type: Venture - Series Unknown
Employee Number: 11-50